Cargando…

A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials

Composite endpoints are commonly used to define primary outcomes in randomized controlled trials. A participant may be classified as meeting the endpoint if they experience an event in one or several components (eg, a favorable outcome based on a composite of being alive and attaining negative cultu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Tra My, White, Ian R., Kahan, Brennan C., Morris, Tim P., Stanworth, Simon J., Forbes, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614656/
https://www.ncbi.nlm.nih.gov/pubmed/34590333
http://dx.doi.org/10.1002/sim.9203
_version_ 1783605632750845952
author Pham, Tra My
White, Ian R.
Kahan, Brennan C.
Morris, Tim P.
Stanworth, Simon J.
Forbes, Gordon
author_facet Pham, Tra My
White, Ian R.
Kahan, Brennan C.
Morris, Tim P.
Stanworth, Simon J.
Forbes, Gordon
author_sort Pham, Tra My
collection PubMed
description Composite endpoints are commonly used to define primary outcomes in randomized controlled trials. A participant may be classified as meeting the endpoint if they experience an event in one or several components (eg, a favorable outcome based on a composite of being alive and attaining negative culture results in trials assessing tuberculosis treatments). Partially observed components that are not missing simultaneously complicate the analysis of the composite endpoint. An intuitive strategy frequently used in practice for handling missing values in the components is to derive the values of the composite endpoint from observed components when possible, and exclude from analysis participants whose composite endpoint cannot be derived. Alternatively, complete record analysis (CRA) (excluding participants with any missing components) or multiple imputation (MI) can be used. We compare a set of methods for analyzing a composite endpoint with partially observed components mathematically and by simulation, and apply these methods in a reanalysis of a published trial (TOPPS). We show that the derived composite endpoint can be missing not at random even when the components are missing completely at random. Consequently, the treatment effect estimated from the derived endpoint is biased while CRA results without the derived endpoint are valid. Missing at random mechanisms require MI of the components. We conclude that, although superficially attractive, deriving the composite endpoint from observed components should generally be avoided. Despite the potential risk of imputation model mis-specification, MI of missing components is the preferred approach in this study setting.
format Online
Article
Text
id pubmed-7614656
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-76146562023-06-15 A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials Pham, Tra My White, Ian R. Kahan, Brennan C. Morris, Tim P. Stanworth, Simon J. Forbes, Gordon Stat Med Article Composite endpoints are commonly used to define primary outcomes in randomized controlled trials. A participant may be classified as meeting the endpoint if they experience an event in one or several components (eg, a favorable outcome based on a composite of being alive and attaining negative culture results in trials assessing tuberculosis treatments). Partially observed components that are not missing simultaneously complicate the analysis of the composite endpoint. An intuitive strategy frequently used in practice for handling missing values in the components is to derive the values of the composite endpoint from observed components when possible, and exclude from analysis participants whose composite endpoint cannot be derived. Alternatively, complete record analysis (CRA) (excluding participants with any missing components) or multiple imputation (MI) can be used. We compare a set of methods for analyzing a composite endpoint with partially observed components mathematically and by simulation, and apply these methods in a reanalysis of a published trial (TOPPS). We show that the derived composite endpoint can be missing not at random even when the components are missing completely at random. Consequently, the treatment effect estimated from the derived endpoint is biased while CRA results without the derived endpoint are valid. Missing at random mechanisms require MI of the components. We conclude that, although superficially attractive, deriving the composite endpoint from observed components should generally be avoided. Despite the potential risk of imputation model mis-specification, MI of missing components is the preferred approach in this study setting. 2021-12-20 2021-09-29 /pmc/articles/PMC7614656/ /pubmed/34590333 http://dx.doi.org/10.1002/sim.9203 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Pham, Tra My
White, Ian R.
Kahan, Brennan C.
Morris, Tim P.
Stanworth, Simon J.
Forbes, Gordon
A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials
title A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials
title_full A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials
title_fullStr A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials
title_full_unstemmed A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials
title_short A comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials
title_sort comparison of methods for analyzing a binary composite endpoint with partially observed components in randomized controlled trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614656/
https://www.ncbi.nlm.nih.gov/pubmed/34590333
http://dx.doi.org/10.1002/sim.9203
work_keys_str_mv AT phamtramy acomparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT whiteianr acomparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT kahanbrennanc acomparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT morristimp acomparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT stanworthsimonj acomparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT forbesgordon acomparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT phamtramy comparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT whiteianr comparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT kahanbrennanc comparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT morristimp comparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT stanworthsimonj comparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials
AT forbesgordon comparisonofmethodsforanalyzingabinarycompositeendpointwithpartiallyobservedcomponentsinrandomizedcontrolledtrials